Syncom Formulations (India) Limited (BOM:524470)
India flag India · Delayed Price · Currency is INR
11.86
-0.14 (-1.17%)
At close: Mar 9, 2026

Syncom Formulations (India) Company Description

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally.

It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments.

The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms.

It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent.

Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Syncom Formulations (India) Limited
Country India
Founded 1988
Industry Pharmaceutical Preparations
Employees 744
CEO Vijay Bankda

Contact Details

Address:
Syncom House
Indore, 452018
India
Phone 91 73 1270 0458
Website syncomformulations.com

Stock Details

Ticker Symbol 524470
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Vijay Bankda Chief Executive Officer
Rahul Bankda Chief Financial Officer